Total Payments
$564.98
2024 Payments
$161.70
Companies
3
Transactions
25
Medicare Patients
256
Medicare Billing
$23,924
Payment Breakdown by Category
Food & Beverage$564.98 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $564.98 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $294.16 | 11 | $0 (2024) |
| ABBVIE INC. | $223.27 | 12 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $47.55 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $161.70 | 7 | Takeda Pharmaceuticals U.S.A., Inc. ($98.39) |
| 2023 | $122.52 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($81.44) |
| 2022 | $151.96 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($92.86) |
| 2021 | $128.80 | 6 | AbbVie Inc. ($107.33) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: IMMUNOLOGY | ||||||
| 05/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/28/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/27/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: IMMUNOLOGY | ||||||
| 05/23/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/03/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: VIROLOGY | ||||||
| 04/25/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: VIROLOGY | ||||||
| 12/19/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/13/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.44 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/22/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/21/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2021 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/26/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: IMMUNOLOGY | ||||||
| 06/23/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: IMMUNOLOGY | ||||||
| 05/06/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 52 | 52 | $66,336 | $4,655 |
| 2022 | 3 | 81 | 81 | $112,626 | $7,743 |
| 2021 | 3 | 104 | 105 | $148,627 | $9,457 |
| 2020 | 1 | 19 | 20 | $24,854 | $2,070 |
Total Patients
256
Total Services
258
Medicare Billing
$23,924
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 29 | 29 | $36,768 | $2,526 | 6.9% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 23 | 23 | $29,568 | $2,129 | 7.2% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 44 | 44 | $57,696 | $3,908 | 6.8% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 22 | 22 | $34,674 | $2,368 | 6.8% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 15 | 15 | $20,256 | $1,467 | 7.2% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 62 | 63 | $78,771 | $5,536 | 7.0% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 27 | 27 | $43,378 | $2,379 | 5.5% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2021 | 15 | 15 | $26,478 | $1,542 | 5.8% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2020 | 19 | 20 | $24,854 | $2,070 | 8.3% |
About Sara White
Sara White is a Pain Management healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2017. The National Provider Identifier (NPI) number assigned to this provider is 1851837348.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sara White has received a total of $564.98 in payments from pharmaceutical and medical device companies, with $161.70 received in 2024. These payments were reported across 25 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($564.98).
As a Medicare-enrolled provider, White has provided services to 256 Medicare beneficiaries, totaling 258 services with total Medicare billing of $23,924. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Management
- Other Specialties Certified Registered|Nurse Anesthetist, Certified Registered
- Location Dallas, TX
- Active Since 01/09/2017
- Last Updated 10/08/2024
- Taxonomy Code 163WP0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851837348
Products in Payments
- ENTYVIO (Biological) $241.30
- HUMIRA (Biological) $107.33
- RINVOQ (Biological) $68.54
- GATTEX (Drug) $52.86
- DUPIXENT (Biological) $47.55
- MAVYRET (Drug) $28.06
- SKYRIZI (Biological) $19.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.